Lipid metabolic reprogramming in hepatic ischemia – reperfusion injury

Nature Medicine 24, 6 (2018).
doi:10.1038/nm.4468

Author: Satdarshan P Monga
In a recent study of hepatic ischemia–reperfusion injury (IRI), Zhang et al. use tandem 'omics' approaches in mice, pigs, and nonhuman primates to identify lipid metabolic reprogramming as a key determinant of IRI, thus providing novel mechanistic and therapeutic insights.

Source: Nature Medicine - January 9, 2018 Category: General Medicine Authors: Satdarshan P Monga Tags: News and Views Source Type: research